Skip to main content

Table 2 Sensitization profile and associated allergic conditions at time of consultation

From: Severity and disease control before house dust mite immunotherapy initiation: ANTARES a French observational survey

 

AIT

(N = 1212)

No-AIT

(N = 377)

Total

(N = 1589)

Patients with polysensitization (n,  %)

 Children (N = 625)

  N available

476

135

611

  Missing

13

1

14

  n (%)

242 (50.8 %)

73 (54.1 %)

315 (51.6 %)

 Adults (N = 938)

  N available

686

222

908

  Missing

23

7

30

  n (%)

425 (62.0 %)

111 (50.0 %)

536 (59.0 %)

 Total (n = 1589)a

   

  N available

1170

366

1536

  Missinga

42

11

53

  n (%)

673 (57.5 %)

190 (51.9 %)

863 (56.2 %)

Patients with asthma (n,  %)

 Children (N = 625)

  N available

489

136

625

  Missing

0

0

0

  n (%)

231 (47.2 %)

48 (35.3 %)

279 (44.6 %)

 Adults (N = 938)

  N available

709

229

938

  Missing

0

0

0

  n (%)

274 (38.6 %)

54 (23.6 %)

328 (35.0 %)

 Total (N = 1589)a

  N available

1212

377

1589

  Missing

0

0

0

  n (%)

507 (41.8 %)

106 (28.1 %)

613 (38.6 %)

Patients with conjunctivitis (n,  %)

 Children (N = 625)

  N available

477

132

609

  Missing

12

4

16

  n (%)

259 (54.3 %)

50 (37.9 %)

309 (50.7 %)

 Adults (N = 625)

  N available

687

225

912

  Missing

22

4

26

  n (%)

398 (57.9 %)

108 (48.0 %)

506 (55.5 %)

 Total (N = 1589)a

  N available

1176

369

1545

  Missing

36

8

44

  n (%)

664 (56.5 %)

167 (45.3 %)

831 (53.8 %)

  1. aThe total population corresponding to the analysis population (N = 1589) that included patients with missing age (N = 26)